Corneal Transplant Market Research Report - Forecast till 2030

Corneal Transplant Market Information: By Type (Penetrating Keratoplasty, Corneal Graft), Indication (Corneal Stromal Dystrophies, Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis), End User (Hospitals) - Forecast till 2030

ID: MRFR/MED/3107-HCR | February 2021 | Region: Global | 110 pages         

Corneal Transplant Market

The corneal transplant market is growing at a fast rate with the rise in the number of eyesight-related corneal problems globally

Segmentation

By Type Penetrating Keratoplasty Corneal Graft
By Indication Corneal Stromal Dystrophies Fungal Corneal Ulcer Bullous Keratopathy Keratoconus Keratitis

Key Players

  • CryoLife Inc. (U.S.)
  • Exactech Inc. (U.S.)
  • Köhler GmbH (U.S.)
  • Lifeline Scientific (U.S)
  • LifeCell Corporation (U.S.)
  • Medtronic (U.S.)
  • Organogenesis Inc. (U.S.)

Drivers

  • High prevalence of corneal eye disease
  • Rising number of corneal transplants
Speak to Analyst Request a Free Sample

Corneal Transplant Market Analysis


The corneal transplant market is growing at a fast rate with the rise in the number of eyesight-related corneal problems globally. The cornea is a vital part of the human eye that is very susceptible to damage by an injury or by a disease. The Corneal damage leads to blurred vision or even complete blindness in some cases. 


Corneal transplantation is a  prevalent surgical procedure in treating corneal damage by disease or injury. It is an easy and non-invasive surgical procedure that has a high success rate. The corneal transplant market share is estimated to grow at a Compound Annual Growth Rate (CAGR) of 7.10% over the forecast period (2020-2030). 


The rising prevalence of lifestyle disorders such as diabetes and obesity are leading causes of Corneal disorders. Moreover, this problem is widespread in the geriatric population. 


Covid 19 Analysis


Covid-19 had a negative impact on the corneal transplant market. The health system was overburdened with covid cases so, there was a diversion in attention from other services to covid management. Moreover, the fear of coronavirus led to a sharp decline in the number of patients reaching hospitals for other problems. Therefore, the number of corneal transplantations being performed decreased in the period. 


Restriction in the movement of goods and people dwindled the pharmaceutical industry causing irregularities in the corneal transplant market. Moreover, the closure of medical devices manufacturing units to halt several medical operations worldwide. However, the corneal transplant market is showing a quick recovery after the relaxation of restriction measures globally.  


Market Dynamics


Drivers


The growing prevalence of ophthalmic diseases owing to a lifestyle change is driving the corneal transplant market. Corneal blindness is a major problem affecting a large population globally and is quite common among geriatric populations. Eyesight disorders are common in people suffering from diabetes, obesity, malnutrition, and other lifestyle-related problems. Corneal transplantation has a high success rate of about 90 % and is getting highly popular. 


Advancements in medical technology are a positive factor for corneal transplant market growth. The acceptance rate of minimally invasive surgeries like corneal transplantation has grown considerably in recent times owing to increasing awareness. Moreover, the number of organ and tissue donations is also rising with increasing literacy rates in different regions of the world. Furthermore, a decrease in operating costs will further fuel the growth of the corneal transplant market.  


Restraints


The high cost of optical devices and transplantation is the major factor hindering the growth of the corneal transplantations market. This factor along with less availability of donors of corneal tissue keeps the large population out of the medical reach. 


Technology Analysis


Corneal transplantation is a procedure of replacing damaged or diseased cornea with healthy donor tissue. It is a method of surgical treatment for several corneal problems which may arise due to eye injury or eye disease. This method is also known as keratoplasty or a corneal graft.


The cornea is a thin and clear outer layer of the eyeball that helps in focusing light rays onto the retina. It also protects the iris, pupil, and other internal parts. Corneal disorders and disease are prevalent worldwide as it is susceptible to damage. Corneal damage leads to blurred vision or even complete blindness sometimes. A doctor recommends corneal transplantation when it cannot be healed or repaired. 


The two major corneal transplantations are Penetrating keratoplasty (full-thickness cornea transplant) and endothelial keratoplasty (back layer cornea transplant). Descemet's stripping automated endothelial keratoplasty, or DSAEK, or DSEK is a relatively newer modification of endothelial keratoplasty that offers quicker recovery. 


Study Objectives


The specific objectives of corneal transplant market report on corneal transplantation are given below: 



  • To provide a complete overview of the corneal transplant market

  • To analyze and forecast the corneal transplant market in terms of value and volume.

  • To provide information about the impact of covid 19 on the market.

  • To identify the problems and prospects of the corneal transplant market.

  • To give details about the technological know-how of the process and products.

  • To provide an overview of the regional market and potentially growing market segments.

  • To identify the key players of the corneal transplantation industry. 


Segment Analysis 


Segmentation of the corneal transplant market, By type



  • Penetrating keratoplasty

  • Endothelial keratoplasty

  • Descemet stripping Automated Endothelial Keratoplasty (DSAEK)

  • Corneal graft

  • Corneal limbal stem cell transplant

  • Others 


The penetrating keratoplasty segment is the largest market segment owing to its ease of performance and higher success rate. It is a full-thickness corneal transplant where a circular portion of the cornea is cut out and replaced with donor tissue. This method helps in the full removal of damaged corneal tissue and improves optical clarity. Moreover, it doesn't hamper corneal anatomy and thereby improves cosmetic appearance.  


Segmentation of the corneal transplant market, By disease indication



  • Fungal keratitis

  • Fuchs’ dystrophy

  • Keratoconus

  • other diseases


Fuchs' dystrophy is the dominating market segment owing to its higher prevalence rate. It is a common disorder having an occurrence rate of about 30 % for both males and females suffering from corneal problems. This problem occurs due to the destruction of endothelium cells in the cornea. The Cornea swells due to fluid buildup and leads to blurred vision. 


However, there has been a significant rise in the case of fungal keratitis which occurs due to improper care and cleaning of the eye.  


Segmentation of the corneal transplant market, By end-users



  • Hospitals

  • Eye clinics

  • Others 


Eye Clinics account for the largest market share. Eye clinics have specialized professionals to deal with eye patients. Moreover, the treatment is quicker in eye clinics than in hospitals.  


Regional Analysis


The different regional markets for the corneal transplant market are: 



  • America

    • North America

      • US

      • Canada

      • Mexico 







  • South America

    • Brazil

    • Argentina 





  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe 





  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia & New Zealand

    • Rest of Asia-Pacific 





  • Rest of the world ( RoW )

    • The Middle East 




Europe is the largest regional segment of the corneal transplant market. Well-developed medical infrastructure and research backup is creating a favorable environment for the growth of the corneal transplant market. There is a considerable emphasis on organ donation programs by Governments and NGOs in this region. Moreover, the high disposable income of the people in this region makes the demand stronger.


The American market is the second-largest market segment. There is a rising demand for corneal transplantation owing to the increasing prevalence of eye-related disorders. According to a study, an average of 40, 000 transplantations are performed daily in the USA. The rising geriatric population and prevalence of lifestyle disorders such as diabetes, hypertension, and obesity are creating a conducive environment for market growth here.


The Asia-Pacific segment is the fastest-growing market segment. Factors like Increasing awareness about transplantation and developing health infrastructure are boosting the market growth here. Moreover, the rise in disposable income of people is generating huge demand for corneal transplantation.


The Middle East and African segment are also expected to grow at a moderate rate. The increasing prevalence of the corneal disease is expected to generate huge demand there.  


Competitive Landscape 


The major global companies playing a key role in the corneal transplant market are :



  • CryoLife, Inc. (U.S.)

  • Exactech, Inc. (U.S.)

  • Köhler GmbH (U.S.)

  • Lifeline Scientific (U.S)

  • LifeCell Corporation (U.S.)

  • Medtronic (U.S.)

  • Organogenesis Inc. (U.S.) 


Recent Developments



  • In April 2019, CorneaGen, a leading American cornea surgical company, announced the acquisition of KeraLink’s domestic eye bank operations and related assets. KeraLink is International, a global leader in corneal transplantation services, supplies, and grafts for transplant. 


Intended Audience


This report will be beneficial for every stakeholder of the corneal transplant market such as :



  • Eye Hospitals

  • Eye Surgery Centers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors 


Report Overview


This report provides an in-depth analysis of the corneal transplant market in terms of current value and future forecast. It aims to provide detailed information about the problems and prospects of the given market. Moreover, the technological analysis section of the product will greatly help in getting better knowledge about the product and its market prospects. Furthermore, this report contains a detailed analysis of every segment of the given market for the current forecast period. This report has also highlighted the key players and the current developments in the corneal transplant market. 



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   7.10% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Indication, and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • High prevalence of corneal eye disease
  • Rising number of corneal transplants


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Corneal transplant market is projected to grow at an 7.10% CAGR between 2020- 2030.

    Europe is expected to dominate the corneal transplant market.

    Rising number of corneal transplants and increasing incidence of corneal eye disease are the key factors driving the corneal transplant market growth.

    High cost may limit the corneal transplant market growth.

    Key players profiled in the corneal transplant market include Organogenesis Inc. (U.S.), Medtronic (U.S.), LifeCell Corporation (U.S.), Lifeline Scientific (U.S), Köhler GmbH (U.S.), Exactech, Inc. (U.S.), and CryoLife, Inc. (U.S.).